+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Contrast Enhanced Ultrasound Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 181 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014747
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The contrast enhanced ultrasound market is rapidly advancing, offering new pathways for clinical imaging and positioning itself as a critical tool for healthcare systems seeking operational efficiency and technology scalability. This analysis provides senior leaders with actionable insights for data-driven decisions in a dynamic healthcare environment.

Market Snapshot: Drivers and Outlook for Contrast Enhanced Ultrasound

Current market momentum for contrast enhanced ultrasound is driven by widespread clinical adoption and a steady flow of innovations in imaging hardware, software platforms, and agent formulations. As its adoption expands—extending from hepatic and oncologic applications to point-of-care and cardiology—institutions increasingly view this technology as a means to optimize diagnostic pathways, streamline daily operations, and reduce dependence on more costly imaging modalities. Evolving regulatory and reimbursement frameworks further reduce institutional resistance, making contrast enhanced ultrasound a viable, scalable solution. Procurements and service models are reshaping to accommodate global shifts, requiring stakeholders to proactively adapt strategies amid ongoing transformation.

Scope & Segmentation of the Contrast Enhanced Ultrasound Market

This comprehensive report analyzes the global contrast enhanced ultrasound landscape by dissecting operational, technological, and regional market drivers. Detailed coverage of established and emerging industry players is provided to help decision-makers benchmark against full value-chain perspectives.

  • Mode: Focuses on Doppler Imaging, Harmonic Imaging, and Real Time Imaging, each enhancing diagnostic accuracy and workflow adaptability.
  • Technology: Examines High Mechanical Index Imaging and Low Mechanical Index Imaging as key categories shaping clinical versatility.
  • Application: Encompasses Cardiology, Emergency Medicine, Oncology, and Radiology, with growing relevance in acute settings and chronic care pathways.
  • End User: Addresses needs of Academic and Research Institutes, Ambulatory Surgical Centers, Diagnostic Imaging Centers, and Hospitals, each demanding unique integration and operational solutions.
  • Geographies: Includes Americas (covering North America and Latin America), Europe, Middle East & Africa, and Asia-Pacific, underscoring regional technology adoption trends and procurement models.
  • Companies: Profiles market leaders such as GE HealthCare Technologies Inc., Koninklijke Philips N.V., Siemens Healthineers AG, Canon Medical Systems Corporation, Samsung Medison Co., Ltd., Fujifilm Holdings Corporation, Bracco Imaging S.p.A., Lantheus Holdings, Inc., Guerbet S.A., and Esaote S.p.A.

Key Takeaways: Strategic Insights for Decision Makers

  • Contrast enhanced ultrasound is rapidly becoming integral to targeted clinical workflows, propelled by transducer and software innovations that are re-defining diagnostic standards.
  • Its reach continues to broaden beyond traditional imaging, supporting multidisciplinary teams with rapid, actionable insights at the point of care, in oncology, and cardiac scenarios.
  • Seamless clinical integration depends on robust staff training programs, operationally efficient reimbursement frameworks, and innovations simplifying contrast administration and agent tracking.
  • Competitive dynamics are intensifying as industry players differentiate on cloud-based analytics, ecosystem partnerships, and value-added service offerings beyond core hardware.
  • Healthcare organizations are refining procurement practices to promote flexibility and supply chain resilience; tailored software deployment and cloud-enabled service options are emerging as critical mitigants, especially for smaller centers.
  • Diverse end users require customized approaches: research institutions prioritize protocol innovation, while diagnostic and ambulatory centers focus on rapid deployment and ongoing cost-effectiveness.

Tariff Impact: Navigating 2025 Supply Chain Realities

New 2025 tariff structures are transforming procurement of both devices and consumables within the contrast enhanced ultrasound ecosystem. Increased duties prompt OEMs and distributors to reevaluate supply chains, explore local manufacturing solutions, and adapt pricing strategies to maintain competitiveness. Hospitals and imaging providers are increasingly reliant on extended contracts and modular system architectures to ensure long-term serviceability. Smaller facilities, particularly vulnerable to procurement cost fluctuations, are turning to flexible, software-driven solutions and cloud-enabled service models as effective buffers against supply disruptions.

Methodology & Data Sources

The research is grounded in a mixed-methods approach, combining structured interviews with clinical, procurement, and technology stakeholders, and systematic review of peer-reviewed literature, regulatory documents, and technical analyses. Methodological rigor and triangulation ensure findings are robust, actionable, and validated by subject matter experts.

Why This Report Matters: Actionable Value for Stakeholders

  • Delivers holistic and data-driven analysis to help executives evaluate sustainable imaging investments and technology adoption strategies aligned to institutional needs.
  • Equips procurement and operations leaders to anticipate potential market disruptions, benchmark innovation pathways, and adjust to evolving reimbursement environments in real time.
  • Provides practical recommendations focused on resilient supply chains, optimal product selection, and strategies to expedite clinician acceptance within real-world operational constraints.

Conclusion: Turning Innovation into Operational Impact

Contrast enhanced ultrasound continues to demonstrate operational and clinical value within modern healthcare systems. Successful implementation relies on aligning technology, partnership, and workflow strategies for sustained market impact and improved diagnostic outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of AI-driven perfusion analysis in contrast enhanced ultrasound for precise tumor characterization
5.2. Development of handheld and portable contrast enhanced ultrasound systems for point of care diagnostics in remote settings
5.3. Emergence of targeted microbubble agents enabling molecular imaging and early detection of vascular biomarkers in CEUS
5.4. Expansion of contrast enhanced ultrasound applications in pediatric cardiology with low-dose microbubble protocols and safety validation
5.5. Advancements in fusion imaging combining contrast enhanced ultrasound with CT and MRI for comprehensive lesion evaluation in liver disease
5.6. Regulatory approvals and favorable reimbursement policies accelerating adoption of contrast enhanced ultrasound in emerging markets across Asia and Latin America
5.7. Innovations in nano-sized ultrasound contrast agents for improved tissue penetration and enhanced diagnostic accuracy in deep-seated lesions
5.8. Growth of telemedicine platforms integrating contrast enhanced ultrasound capabilities for remote second opinions and collaborative diagnostics
5.9. Clinical validation of therapeutic ultrasound combined with contrast microbubbles for targeted drug delivery and sonothrombolysis applications
5.10. AI-powered automated anomaly detection and standardized reporting workflows transforming the efficiency of contrast enhanced ultrasound exams
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Contrast Enhanced Ultrasound Market, by Mode
8.1. Doppler Imaging
8.2. Harmonic Imaging
8.3. Real Time Imaging
9. Contrast Enhanced Ultrasound Market, by Technology
9.1. High Mechanical Index Imaging
9.2. Low Mechanical Index Imaging
10. Contrast Enhanced Ultrasound Market, by Application
10.1. Cardiology
10.2. Emergency Medicine
10.3. Oncology
10.4. Radiology
11. Contrast Enhanced Ultrasound Market, by End User
11.1. Academic and Research Institutes
11.2. Ambulatory Surgical Centers
11.3. Diagnostic Imaging Centers
11.4. Hospitals
12. Contrast Enhanced Ultrasound Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Contrast Enhanced Ultrasound Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Contrast Enhanced Ultrasound Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. GE HealthCare Technologies Inc.
15.3.2. Koninklijke Philips N.V.
15.3.3. Siemens Healthineers AG
15.3.4. Canon Medical Systems Corporation
15.3.5. Samsung Medison Co., Ltd.
15.3.6. Fujifilm Holdings Corporation
15.3.7. Bracco Imaging S.p.A.
15.3.8. Lantheus Holdings, Inc.
15.3.9. Guerbet S.A.
15.3.10. Esaote S.p.A.

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Contrast Enhanced Ultrasound market report include:
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • Canon Medical Systems Corporation
  • Samsung Medison Co., Ltd.
  • Fujifilm Holdings Corporation
  • Bracco Imaging S.p.A.
  • Lantheus Holdings, Inc.
  • Guerbet S.A.
  • Esaote S.p.A.

Table Information